Gastrointestinal Cancer

Explore the latest updates, including expert interviews and features

The GI Cancer Channel on VJOncology is supported by Seagen. This supporter has no influence over the production of the content.

Latest videos VJSessions Subtypes Topics Conferences Features Editorial Board

Welcome to the Gastrointestinal Cancer Channel!

Catch up on the latest developments in gastrointestinal cancer with VJOncology, featuring exclusive interviews, podcasts, and expert-led roundtable discussions.

Genomic biomarkers in metastatic colorectal cancer

Subtypes

Gastric Cancer
Colorectal Cancer
Liver Cancer
Bile Duct Cancer
Pancreatic Cancer
0:27
RATIONALE-305: tislelizumab + chemo vs placebo +chemo in advanced GC/GEJC
Tania C. Fleitas • 22 Oct 2023
1:45
1L nivo + low dose ipi in pts with advanced gastric or esophago-gastric junction MSI-H tumors
Kei Muro • 23 Oct 2023
8:01
INNOVATION: chemotherapy with trastuzumab and pertuzumab in HER2+ gastric cancer
Anna Wagner • 29 Jun 2023
2:17
Claudin 18.2 and FGFR2b as novel targets in gastric cancer
Filippo Pietrantonio • 29 Jun 2023
View All Videos
1:25
Real-world treatment patterns for HER2-amplified colorectal cancer
John Strickler • 21 Oct 2023
3:15
Predictive biomarkers for RAS-wt mCRC treated with cetuximab and m-FOLFOXIRI
Yu Sunakawa • 21 Oct 2023
0:33
BRAF testing in CRC: comprehensive approach across all stages, affordability, and global advocacy
Julien Taieb • 20 Oct 2023
0:47
Highlighting the benefits of KRAS testing in colorectal cancer
Filippo Pietrantonio • 22 Oct 2023
View All Videos
3:07
HCC and CCA trials at ESMO 2023: AdvanTIG-206 and ABC-01
Lorenza Rimassa • 23 Oct 2023
1:26
The role of monotherapy TKI’s in the treatment of patients with hepatocellular carcinoma
Stephen L. Chan • 23 Oct 2023
1:13
Choosing the best treatment regimen in advanced hepatocellular carcinoma
Jeroen Dekervel • 30 Jun 2023
3:14
RATIONALE-301: elderly subgroup analysis of tislelizumab in HCC
Arndt Vogel • 3 Jul 2023
View All Videos
0:33
Advancing precision medicine: exploring ctDNA analysis beyond rectal cancer
Changhoon Yoo • 3 Jun 2023
2:47
Sub-analysis of STAMP trial: ctDNA as predictive biomarker for CCA monitoring during ACT
Changhoon Yoo • 3 Jun 2023
2:27
Advances in FGFR inhibition for hepatobiliary cancer
Arndt Vogel • 3 Jul 2023
1:14
HRQoL in KEYNOTE-966: pembrolizumab with gemcitabine and cisplatin for advanced biliary tract cancer
Changhoon Yoo • 3 Jun 2023
View All Videos
0:56
Elucidating the role of immunotherapy in pancreatic cancer
Akihiro Ohba • 22 Oct 2023
1:09
What are the current unmet needs in metastatic pancreatic cancer?
Akihiro Ohba • 22 Oct 2023
1:33
JCOG1611: nab-paclitaxel/gemcitabine vs. FOLFIRINOX/S-IROX in met or recurrent pancreatic cancer
Akihiro Ohba • 22 Oct 2023
1:28
How much progress have we made in targeting KRAS in GI malignancies?
Benedikt Westphalen • 23 Oct 2023
View All Videos

Topics

Immuno-Oncology
CAR-T & Cellular Therapy
Trial Updates
Molecular Profiling
Radiotherapy
3:15
Predictive biomarkers for RAS-wt mCRC treated with cetuximab and m-FOLFOXIRI
Yu Sunakawa • 21 Oct 2023
0:56
Elucidating the role of immunotherapy in pancreatic cancer
Akihiro Ohba • 22 Oct 2023
0:27
RATIONALE-305: tislelizumab + chemo vs placebo +chemo in advanced GC/GEJC
Tania C. Fleitas • 22 Oct 2023
3:07
HCC and CCA trials at ESMO 2023: AdvanTIG-206 and ABC-01
Lorenza Rimassa • 23 Oct 2023
View All Videos
1:53
SCG101: a novel T-cell therapy in advanced hepatitis B-related HCC
Ghassan Abou-Alfa • 22 Jun 2023
1:13
TACTIC-2: TAC01-HER2, a TAC T-cell therapy, in HER2+ tumors
Benjamin Schlechter • 4 Jun 2023
0:42
Treating HER2-positive solid tumors with TAC T-cell therapy
Benjamin Schlechter • 4 Jun 2023
0:41
How can immunotherapies successfully target MSS colorectal cancer?
Benny Johnson • 17 Apr 2023
View All Videos
3:15
Predictive biomarkers for RAS-wt mCRC treated with cetuximab and m-FOLFOXIRI
Yu Sunakawa • 21 Oct 2023
1:39
SANO-trial: neoadjuvant chemo-RT followed by surgery vs. active surveillance for oesophageal cancer
Berend J. Van der Wilk • 21 Oct 2023
1:33
JCOG1611: nab-paclitaxel/gemcitabine vs. FOLFIRINOX/S-IROX in met or recurrent pancreatic cancer
Akihiro Ohba • 22 Oct 2023
1:45
1L nivo + low dose ipi in pts with advanced gastric or esophago-gastric junction MSI-H tumors
Kei Muro • 23 Oct 2023
View All Videos
1:25
Real-world treatment patterns for HER2-amplified colorectal cancer
John Strickler • 21 Oct 2023
3:15
Predictive biomarkers for RAS-wt mCRC treated with cetuximab and m-FOLFOXIRI
Yu Sunakawa • 21 Oct 2023
0:33
BRAF testing in CRC: comprehensive approach across all stages, affordability, and global advocacy
Julien Taieb • 20 Oct 2023
0:29
Does ctDNA have a role in identifying actionable mutations in CRC?
Davide Ciardiello • 23 Oct 2023
View All Videos
2:34
Consolidation chemoradiation vs observation after 1L chemotherapy in advanced gall bladder cancers
Sushma Agrawal • 3 Jun 2023
0:32
Unmet needs for gallbladder cancers
Sushma Agrawal • 4 Jun 2023
1:32
AN0025 with chemoradiotherapy in advanced rectal cancer
Lucjan Wyrwicz • 29 Jun 2023
0:32
Unmet needs of gallbladder cancers
Sushma Agrawal • 3 Jun 2023
View All Videos

Conferences

ESMO WCGIC
ASCO 2023
AACR 2023
GI Malignancies 2023
ASCO GI 2023
ASCO 2022
0:36
What are the current unmet needs in anal cancer?
Juan Manuel O'Connor • 30 Jun 2023
1:04
NCI9673: nivolumab with or without ipilimumab in anal cancer
Juan Manuel O'Connor • 30 Jun 2023
8:22
Colorectal trials at WCGIC 2023: VELO, DEEPER, IMPROVE and AVETRIC
Shouki Bazarbashi • 29 Jun 2023
2:41
The future of liquid biopsies in gastrointestinal malignancies
Filippo Pietrantonio • 29 Jun 2023
View All Videos
2:34
Consolidation chemoradiation vs observation after 1L chemotherapy in advanced gall bladder cancers
Sushma Agrawal • 3 Jun 2023
1:55
Belzutifan real-world vs clinical trial data: comparing efficacy and safety in VHL-associated tumors
Anusha Chidharla • 3 Jun 2023
1:28
Belzutifan as a non-invasive treatment option for VHL-associated tumors
Anusha Chidharla • 3 Jun 2023
2:09
Promising real-world outcomes of belzutifan in VHL-associated tumors
Anusha Chidharla • 3 Jun 2023
View All Videos
2:53
The emerging role of MRD in colorectal cancer decision making
Benny Johnson • 17 Apr 2023
1:12
Targeted therapies in metastatic colorectal cancer
Benny Johnson • 17 Apr 2023
1:19
Phase I/II trial of EP0031, a next generation selective RET inhibitor
Vivek Subbiah • 17 Apr 2023
1:05
Limitations in immune checkpoint inhibitors in treating gastric cancer
Yelena Janjigian • 18 Apr 2023
View All Videos
1:28
ctDNA testing in pancreatic cancer and other upper GI malignancies
Suneel Kamath • 4 Apr 2023
2:13
Ongoing clinical trials on using ctDNA results to guide GI cancer management
Suneel Kamath • 4 Apr 2023
3:03
The future of radiotherapy as a treatment for pancreatic cancer
Joseph Herman • 28 Mar 2023
4:04
Alliance trials: Combination of modified FOLFIRINOX and radiotherapy for pancreatic cancer
Joseph Herman • 28 Mar 2023
View All Videos
1:07
Updates in colorectal and rectal cancer at ASCO GI 2023
Ardaman Shergill • 26 Jan 2023
1:17
Detecting resistance to treatments in CRC with liquid biopsies
Ardaman Shergill • 26 Jan 2023
1:20
Advances in predicative biomarkers for rectal cancer
Ardaman Shergill • 26 Jan 2023
5:05
Is front-line anti-EFGR therapy essential in RAS-WT mCRC?
Ardaman Shergill • 26 Jan 2023
View All Videos
4:53
Phase I trial of mRNA neoantigen vaccines for pancreatic cancer
Vinod P. Balachandran • 16 Jun 2022
3:17
Development of individualized mRNA neoantigen vaccines for pancreatic cancer
Vinod Balachandran • 16 Jun 2022
1:31
Potential of immunotherapy for pancreatic cancer
Vinod P. Balachandran • 16 Jun 2022
1:13
Next steps for the development of individualised mRNA neoantigen vaccines
Vinod P. Balachandran • 16 Jun 2022
View All Videos

The GI Cancer Channel on VJOncology is supported by Seagen.

This supporter has no influence over the production of the content.

The content of VJOncology is intended for healthcare professionals